The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
|Articles|September 25, 2006
Russell Reynolds to help search for new NACDS head
NACDS has selected the executive search firm of Russell Reynolds Associates to work with the NACDS search committee in recruiting a new president/CEO.
Advertisement
NACDS has selected the executive search firm of Russell Reynolds Associates to work with the NACDS search committee in recruiting a new president/CEO. The effort will be handled by Eric Vautour, managing director of Russell Reynolds? Washington, D.C., office.
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination support, and local health leadership.
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
Advertisement
Advertisement
Trending on Drug Topics
1
What Is HIV PrEP and Who Needs It Most?
2
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
3
Indirect Comparison Links Tirzepatide to Greater Weight Loss Than Semaglutide
4
Validating Fear Before Facts: A Framework for COVID-19 Hesitancy
5